Wire Stories

Canva Introduces Student-Safe AI Products, Customizable Lessons for Teachers, and Over 5,000 Free Classroom Resources to 50 Million Students and Teachers

Releases AI in Education Report, revealing 93% don’t know where to start with AI Unveils…

ImmuneOncia Announces Phase 1 Results of CD47 Antibody at ESMO 2023

SEOUL, South Korea--(BUSINESS WIRE)--ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 1a…

Eli Israeli Joins Odysight.ai as Chief Technology Officer

OMER, Israel, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: SCTC), a leading provider…

Nighthawk Gold Delivers Inaugural ESG Report

TORONTO--(BUSINESS WIRE)--$MIMZF #esg--Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK; OTCQX: MIMZF) delivers its…

Alipay+ partners LankaPay to enhance digital travel experience to and from Sri Lanka

More than 400,000 merchants in Sri Lanka will be able to accept cross-border digital payments…

SkyDrive Selected for Innovation Grant Worth up to 12.4 Billion Yen by Japanese Government

TOYOTA, Japan--(BUSINESS WIRE)--#FlyingCars--SkyDrive Inc. (“SkyDrive”), a leading Japanese eVTOL aircraft (*1) manufacturer based in Japan,…

Fearless, Solid and Reliable, DONGFENG KC Ushers a New Journey in the World

WUHAN, China--(BUSINESS WIRE)--Customer-oriented, in response to the dominance of road transport in many regions around…

HighField Biopharmaceuticals Announces Positive Phase 1a Data of HF1K16, a new Immuno-Oncology Drug, For Patients with Recurrent and Refractory Glioma

HighField CEO Yuhong Xu and CBO Donald Wyatt are attending BIO-Europe, November 6 – 8,…

Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

First market approval for Genexine discovered and developed therapeutic drug, Efesa (Efepoetin alfa), a long-acting…

National Football League Teams Up with SES for Game Content Distribution

In a renewed partnership, SES’s hybrid distribution network to enable the NFL to reach over…